Lancet Oncology Lancet Oncology, Elsevier, 2009, 10 (8), pp.772-784. 〈10.1016/S1470-2045(09)70187-1〉 Lancet Oncology, 10(8), 772-784. ELSEVIER SCIENCE INC Klug, S J, Ressing, M E, Koenig, J, Abba, M C, Agorastos, T, Brenna, S M F, Ciotti, M, Das, B R, Del Mistro, A, Dybikowska, A, Giuliano, A R, Gudleviciene, Z, Gyllensten, U, Haws, A L F, Helland, A, Herrington, C S, Hildesheim, A, Humbey, O, Jee, S H, Kim, J T, Madeleine, M M, Menczer, J, Ngan, H Y S, Nishikawa, A, Niwa, Y, Pegoraro, R, Pillai, M R, Ranzani, G, Rezza, G, Rosenthal, A J, Roychoudhury, S, Saranath, D, Schmitt, V M, Sengupta, S, Settheetham-Ishida, W, Shirasawa, H, Snijders, P J F, Stoler, M H, Suarez-Rincon, A E, Szarka, K, Tachezy, R, Ueda, M, van der Zee, A, Doeberitz, M, Wu, M, Yamashita, T, Zehbe, I & Blettner, M 2009, ' TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies ', Lancet Oncology, vol. 10, no. 8, pp. 772-784 . https://doi.org/10.1016/S1470-2045(09)70187-1 Lancet Oncology, Elsevier, 2009, 10 (8), pp.772-784. ⟨10.1016/S1470-2045(09)70187-1⟩ Lancet Oncology, 10(8), 772-784. Lancet Publishing Group